Pleurectomy

PROCEDURE3 trials

Sponsors

National Cancer Institute (NCI), NRG Oncology, Ain Shams University

Conditions

Biphasic MesotheliomaEpithelioid MesotheliomaPleural Biphasic MesotheliomaPleural Epithelioid MesotheliomaPneumothoraxStage I Pleural Diffuse Malignant Mesothelioma AJCC v7Stage I Pleural Malignant Mesothelioma AJCC v8Stage IA Pleural Diffuse Malignant Mesothelioma AJCC v7

Phase 1

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Active, not recruitingNCT03228537

National Cancer Institute (NCI)Biphasic Mesothelioma, Epithelioid Mesothelioma, Stage IA Pleural Diffuse Malignant Mesothelioma AJCC v7 +4

Start: 2018-07-16End: 2026-09-18Updated: 2026-05-01

Phase 3

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

TerminatedNCT04158141

NRG OncologyPleural Biphasic Mesothelioma, Pleural Epithelioid Mesothelioma, Stage IA Pleural Malignant Mesothelioma AJCC v8 +4

Start: 2020-01-29End: 2023-11-20Updated: 2026-05-19

Unknown Phase

Pleurectomy Versus Pleural Abrasion in Patients With Spontaneous Pneumothorax

Ain Shams UniversityPneumothorax

Start: 2021-10-03End: 2023-05-01Target: 80Updated: 2023-03-24

Related Papers

Pleurectomy versus pleural abrasion in patients with spontaneous pneumothorax: a randomized controlled trial

The Egyptian Journal of Surgery2024-01-01

A phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006).

Journal of Clinical Oncology2020-05-201 citations